🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

My first conference and presenting a moderated poster, very rewarding! Excited for my poster presentation on monday! 🫀🩺#AHA24

Day 2 at AHA Science 2024. Thrilled to have presented 2 abstracts so far, with even more to present tomorrow. Stay tuned! #AHA2024

Last day of #AHA24 with poster presentation! Very happy to have been a part of this! 🫀🇺🇸🇧🇷🩺

Last day of AHA Science 2024! Honored to present a moderated poster on interatrial devices in HFpEF and engage in insightful discussions with leading experts in the field. Grateful for the opportunity to share and learn! #AHA2024 #MedX

Last day at the American Heart Association conference🫀🫀!!! Grateful for the opportunity to present 2️⃣ meta analyses as a first author and to meet so many wondeful people⭐️. I’m honored to work with incredible teamates and mentors!!! Can’t wait to see our future projects #AHA24

Leaving Chicago with amazing news: just found out another paper has been accepted for publication! Grateful for this trip, and it couldn’t have ended on a better note. I’ll share more about the paper soon! #MedX #MedTwitter

Thrilled to share that our meta-analysis has been accepted for publication in Digestive Diseases and Sciences! 🎉 Thank you to all the authors for their support. I’ll share more details once it becomes publicly available! #MedX #endoscopy #gastroenterology

Wrapping up an incredible #AHA24! From early med students to seasoned experts, the #MetaMasters community showed up, shared, and inspired. Safe travels to all — we’re so proud of you! Let’s do it again next year in New Orleans! #CardiologyResearch

As a medical student, presenting my work and connecting with incredible mentors, fellows, and friends at #AHA24 has been truly unforgettable. Moments like this remind me I’m on the right path. Grateful beyond words for everyone who’s supported me, this is just the beginning!

🚨 Exciting news! Our meta-analysis on SGLT2i in MI patients has been accepted for publication in Cardiovascular Diabetology! 🔎 Key findings: ✅ SGLT2i reduced MACE events & heart failure hospitalizations ✅ Supports broader use post-MI Grateful to my co-authors & mentors!🙌

Glad to announce that I’ll be joining the Meta Analysis Academy next cohort as a teaching assistant! A great opportunity to give back to other students after making the best decision of my career!

Welcome to the teaching team! Our future #metamasters will be lucky for counting on your expertise!!

Our updated review demonstrates low rates of syncope recurrence in patients with vasovagal syncope undergoing this innovative procedure. #Cardiology #electrophysiology #MedX #CardioTwitter

👥Systematic meta-analysis of 10 RCTs (>22,000 pts - 51.2% w/T2DM) to determine the impact of SGLT2i in pts w/ recent or previous MI. 🗓️Mean age 62 yrs; median FU was 21 months. Main findings: 💥HF hospitalization rates were ⬇️in pts on SGLT2i compared with placebo (RR 0.77;

Honored to be a co-author in this impactful research! Excited to contribute to advancing knowledge in the field. #CardioTwitter #Cardiology #MedX

🚨 2025 Incredible News! Honored to co-author a high-impact paper published in Heart Rhythm. As a medical student, 🫀 researcher, and future cardiothoracic surgeon, this marks a major milestone in my academic journey. #HeartRhythm #Cardiology #MedicalResearch Meta Analysis Academy

Hello, #MedTwitter Halfway there, heart full of certainty: I'm exactly where I'm supposed to be. Excited for the next steps!🤞🏼⚕️

Excited to share our latest publication! We evaluated TTR-targeting therapies for ATTR-CM and found they significantly improve survival, with no significant difference between TTR gene knockdown therapies and TTR stabilizers. link.springer.com/article/10.118…